Intarcia’s Exenatide Implant Rejected Again As US FDA Denies Comparative Safety Argument

Closed door
FDA has closed the door to approval of Intarcia's ITCA 650. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Product Reviews

More from Pink Sheet